FDA Clearance Tracker · K253536
Evala Nerve Stimulator (EPNR002)
Last checked: Nov 19, 2026Latest source record: Feb 27, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Feb 27, 2026
Substantially Equivalent
Time to decision
106 days
Received Nov 13, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K253536
- Device name
- Evala Nerve Stimulator (EPNR002)
- Applicant
- Epineuron Technologies, Inc.
- Applicant location
- Mississauga, CA
- Received
- Nov 13, 2025
- Decided
- Feb 27, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Stimulator, Nerve (ETN)
- Device class
- Class II
- Regulation
- 21 CFR 874.1820
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code ETN. The earliest in FDA's data is K781569, decided Dec 7, 1978.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K253536
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Epineuron Technologies, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.